Enlivex Therapeutics Ltd

NASDAQ:ENLV   3:59:58 PM EDT
4.48
+0.18 (+4.19%)
Earnings Announcements

Enlivex Announces Second Quarter 2022 Financial Results And Provides Business Update

Published: 08/22/2022 12:20 GMT
Enlivex Therapeutics Ltd (ENLV) - Enlivex Announces Second Quarter 2022 Financial Results and Provides a Business Update.
Enlivex Therapeutics Ltd - As of June 30, 2022, Co Had Cash, Cash Equivalents, and Short-term Deposits of $62.5 Million.
Enlivex Therapeutics Ltd - Believes Existing Cash Equivalents Will Be Sufficient to Fund Operating Expenses and Capex Requirements Through Q3 of 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.